Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIPLOID: Tacrolimus PK Interaction with Verapamil
NCT04489134Phase 2Completed
- Sponsor
- CHU Rennes
- Start
- Feb 2022
- Primary completion
- May 2023
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus in kidney transplant rejection, sponsored by CHU Rennes. Started Feb 2022; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT04489134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04489134.